Verwendung eines Mittels und Vorrichtung zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma

Extracorporeal removal of tumour necrosis factor- alpha (TNF- alpha ) and/'or bacterial lipopolysaccharides (LPS, endotoxin) from whole blood and/or blood plasma is carried out with a perfusion system contg. cationic and anionic exchange material. Also claimed is a device based on this techniqu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TRAUTWEIN, ANNETTE, 67454 HASLOCH, DE, SEIDEL, DIETRICH, DR., 82340 FELDAFING, DE, MORSCH, GEROLD., 34628 WILLINGHAUSEN, DE, BOOS, KARL-SIEGFRIED, .-BIO. DR., 81131 GAUTING, DE
Format:	Patent
Sprache:	ger
Schlagworte:	CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOIDCHEMISTRY CHEMISTRY DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PERFORMING OPERATIONS PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SEPARATION THEIR RELEVANT APPARATUS TRANSPORTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Extracorporeal removal of tumour necrosis factor- alpha (TNF- alpha ) and/'or bacterial lipopolysaccharides (LPS, endotoxin) from whole blood and/or blood plasma is carried out with a perfusion system contg. cationic and anionic exchange material. Also claimed is a device based on this technique for the treatment of patient blood and/or plasma and which is capable of simultaneous removal of TNF- alpha and LPS is described.